Oxford Nanopore Technologies (ONT) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Apr 2024 12:00 PM
RNS
LTIP and DBP; Director/PDMR Notification
11 Apr 2024 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
08 Apr 2024 04:00 PM
RNS
Block Listing Interim Review
02 Apr 2024 02:00 PM
RNS
Issue of Equity and Total Voting Rights
28 Mar 2024 05:55 PM
RNS
Holding(s) in Company
12 Mar 2024 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
12 Mar 2024 07:00 AM
RNS
Oxford Nanopore to Present at Barclays Conference
08 Mar 2024 12:00 PM
RNS
Director/PDMR Shareholding
07 Mar 2024 07:00 AM
RNS
Director/PDMR Shareholding
06 Mar 2024 07:00 AM
RNS
FY23 Preliminary Results
01 Mar 2024 02:00 PM
RNS
Issue of Equity and Total Voting Rights
29 Feb 2024 06:00 PM
RNS
Directorate Change
13 Feb 2024 04:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
02 Feb 2024 04:30 PM
RNS
Holding(s) in Company
01 Feb 2024 12:00 PM
RNS
Issue of Equity and Total Voting Rights
22 Jan 2024 07:00 AM
RNS
Expansion of leadership team
11 Jan 2024 05:30 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
11 Jan 2024 05:30 PM
RNS
Employee Stock Purchase Plan - PDMR Notification
09 Jan 2024 07:00 AM
RNS
FY23 trading update
03 Jan 2024 07:00 AM
RNS
Presentation at 42nd Annual J.P. Morgan Conference
02 Jan 2024 04:00 PM
RNS
Director/PDMR Shareholding (ESPP)
02 Jan 2024 04:00 PM
RNS
Issue of Equity and Total Voting Rights
19 Dec 2023 02:00 PM
RNS
Appointment of Two Non-Executive Directors
12 Dec 2023 05:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
07 Dec 2023 04:30 PM
RNS
Nanopore Community Meeting Technology Update
01 Dec 2023 05:00 PM
RNS
Issue of Equity and Total Voting Rights
30 Nov 2023 07:00 AM
RNS
National Australian rare disease programme
13 Nov 2023 05:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
13 Nov 2023 12:00 PM
RNS
Participation in upcoming investor conferences
07 Nov 2023 08:30 AM
RNS
Admission to Trading on the London Stock Exchange
06 Nov 2023 07:00 AM
RNS
Issue of Equity
01 Nov 2023 04:00 PM
RNS
Issue of Equity and Total Voting Rights
31 Oct 2023 07:00 AM
RNS
Apple showcases Oxford Nanopore in M3 launch
26 Oct 2023 06:10 PM
RNS
Holding(s) in Company
24 Oct 2023 12:30 PM
RNS
Holding(s) in Company
23 Oct 2023 08:30 AM
RNS
Admission to Trading on the London Stock Exchange
23 Oct 2023 08:30 AM
RNS
Issue of Equity and Total Voting Rights
19 Oct 2023 07:00 AM
RNS
Capital Markets Day - ONT expands into clinical
19 Oct 2023 07:00 AM
RNS
bioMérieux makes investment in Oxford Nanopore
19 Oct 2023 07:00 AM
RNS
Mayo Clinic and Oxford Nanopore collaboration
11 Oct 2023 03:30 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
06 Oct 2023 03:00 PM
RNS
Block Listing Interim Review
02 Oct 2023 04:00 PM
RNS
Issue of Equity and Total Voting Rights
27 Sep 2023 05:00 PM
RNS
Director Declaration
27 Sep 2023 05:00 PM
RNS
Director Declaration
12 Sep 2023 03:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
12 Sep 2023 07:00 AM
RNS
Presentation at the Morgan Stanley Conference
06 Sep 2023 07:00 AM
RNS
Interim results for the 6 months ended 30 June 23
01 Sep 2023 03:00 PM
RNS
Issue of Equity and Total Voting Rights
25 Aug 2023 12:00 PM
RNS
Notice of Results and Capital Markets Day

Oxford Nanopore Technologies develops electronic sensing systems for analyzing DNA, RNA, proteins, and other molecules including DNA sequencing, diagnostics and drug development using uses nanopore science to develop single-molecule sensing systems. Their products are used in research areas such as microbiology, human genetics, cancer research, and plant research.

Founded in 2005 as a spin-out from the University of Oxford, Oxford Nanopore is listed in London under the ticker ONT.

Oxford Nanopore share price listed at 615p in 2021.

UK 100

Latest directors dealings